Insider Transactions in Q2 2022 at Biora Therapeutics, Inc. (BIOR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Surbhi Sarna Director |
BUY
Grant, award, or other acquisition
|
Direct |
96,154
+38.09%
|
-
|
|
Jun 15
2022
|
Lynne Powell |
BUY
Grant, award, or other acquisition
|
Direct |
96,154
+40.09%
|
-
|
|
Jun 15
2022
|
Jeffrey D. Alter |
BUY
Grant, award, or other acquisition
|
Direct |
96,154
+37.01%
|
-
|
|
Jun 15
2022
|
Jill Ann Howe |
BUY
Grant, award, or other acquisition
|
Direct |
96,154
+35.74%
|
-
|
|
Jun 15
2022
|
Brian L. Kotzin |
BUY
Grant, award, or other acquisition
|
Direct |
96,154
+40.09%
|
-
|
|
May 15
2022
|
Eric D Esparbes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
292,406
+29.31%
|
-
|
|
May 15
2022
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,387
-2.45%
|
$0
$0.75 P/Share
|
|
May 15
2022
|
Aditya P. Mohanty Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,562,500
+34.44%
|
-
|
|
May 15
2022
|
Clarke Neumann |
BUY
Grant, award, or other acquisition
|
Direct |
239,962
+30.44%
|
-
|
|
May 15
2022
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
8,305
-2.62%
|
$0
$0.75 P/Share
|
|
Apr 15
2022
|
Clarke Neumann |
BUY
Grant, award, or other acquisition
|
Direct |
184,843
+36.86%
|
-
|
|
Apr 15
2022
|
Eric D Esparbes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
231,693
+35.38%
|
-
|